TrianglePUBLICATIONS · 26731483
Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Neuroendocrinology
- Publication date
- 2017
- First author
- Rinke A
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Rinke A
- type
- Author
- name
- Wittenberg M
- type
- Author
- name
- Schade-Brittinger C
- type
- Author
- name
- Aminossadati B
- type
- Author
- name
- Ronicke E
- type
- Author
- name
- Gress TM
- type
- Author
- name
- Müller HH
- type
- Author
- name
- Arnold R
- type
- Author
- name
- PROMID Study Group
- type
- CollectiveName
Complete bibliographic record and source provenance
- authors
- name
- Rinke A
- type
- Author
- name
- Wittenberg M
- type
- Author
- name
- Schade-Brittinger C
- type
- Author
- name
- Aminossadati B
- type
- Author
- name
- Ronicke E
- type
- Author
- name
- Gress TM
- type
- Author
- name
- Müller HH
- type
- Author
- name
- Arnold R
- type
- Author
- name
- PROMID Study Group
- type
- CollectiveName
- bibliography ids
- nci-bib-89c26764aa4acd5429f15de1
- book metadata
- content sha256
- 19e70fc77138077b366e5e33c547aba43554dfba51857fc5c3498fa62a983a9c
- document type
- citation
- dois
- 10.1159/000443612
- electronic publication date
- display
- 2016 Jan 6
- precision
- day
- year
- 2016
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:26731483
- immutable id
- pubmed:26731483@19e70fc77138077b366e5e33c547aba43554dfba51857fc5c3498fa62a983a9c
- journal
- abbreviation
- Neuroendocrinology
- issn electronic
- 1423-0194
- issn print
- 0028-3835
- issue
- 1
- name
- Neuroendocrinology
- nlm unique id
- 0035665
- pages
- 26-32
- volume
- 104
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 26731483
- provenance
- batch id
- 948d34b0dea86780a31d
- provider
- NCBI PubMed ESummary
- record sha256
- 7c1a954a9190060a62546e95cefc665fa09b69e0b3aaaecb63bbe85102ac95a5
- response sha256
- 11c34185eb9e4ea0d3c4d255d31806495349b0f097d492c4e135946541bf4bb5
- retrieved at
- 2026-09-09T23:47:15.495091+00:00
- publication date
- display
- 2017
- precision
- year
- year
- 2017
- publication types
- Journal Article
- Randomized Controlled Trial
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients with Metastatic Neuroendocrine Midgut Tumors (PROMID): Results of Long-Term Survival.
Preserved source evidence · Not medical advice